Photo from Steven Frank/X
May 29, 2024, 09:13
Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO
Steven Frank, Executive Director of Particle Therapy Institute at MD Anderson Cancer Center, shared on X:
“Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO on June 4th.” .
View additional information.
Source: Steven Frank/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07
Nov 21, 2024, 17:57